Self-stabilized Pt(IV) amphiphiles by precise regulation of branch length for enhanced chemotherapy

Xiao Kuang1, Yuting Hu1, Dongxu Chi1

  • 1Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.

Insights

Researchers developed new platinum(IV) lipid prodrugs that self-assemble into nanomedicines. These compounds show improved cancer treatment efficacy by activating within tumor cells, offering a promising approach for chemotherapy delivery.

Area of Science:

  • Nanomedicine
  • Cancer Therapeutics
  • Drug Delivery Systems

Background:

  • Platinum(IV) compounds are investigated for cancer treatment but face challenges with adverse effects and limited efficacy due to poor tumor targeting and activation.
  • Existing platinum-based chemotherapeutics often suffer from nonspecific distribution and insufficient activation at the tumor site, hindering their therapeutic potential.

Purpose of the Study:

  • To design and synthesize novel disulfide bond-introduced platinum(IV)-lipid prodrugs with varying branch lengths.
  • To investigate the structure-activity relationship of these prodrugs concerning their self-assembly, pharmacokinetics, and cytotoxicity.
  • To establish a reduction-responsive platinum delivery system for enhanced cancer therapy.

Main Methods:

  • Synthesis of a series of Pt(IV)-lipid prodrugs featuring disulfide bonds and differing axial branch lengths.
  • Characterization of prodrug self-assembly into nanomedicines.
  • Evaluation of prodrug stability, pharmacokinetics, and in vitro cytotoxicity, particularly in response to intracellular glutathione (GSH) levels.

Main Results:

  • The designed Pt(IV)-lipid prodrugs self-stabilized into nanomedicines, demonstrating activation by high intracellular glutathione (GSH) levels.
  • Modifications in prodrug structure significantly impacted assembly stability, pharmacokinetics, and cytotoxicity.
  • The Pt(IV) prodrug with the longest axial branch (CSS18) showed superior assembly, delivery efficacy, and the most significant therapeutic outcome.

Conclusions:

  • Chemical modulation of Pt(IV)-lipid prodrugs enables the rational design of efficient, self-stabilizing nanocarriers.
  • The developed reduction-responsive platinum delivery system, exemplified by CSS18, offers a promising strategy for improving cancer chemotherapeutic outcomes.
  • This study provides insights into designing advanced nanomedicines for targeted and effective cancer treatment.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
31
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K